{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:31:29Z","timestamp":1790872289140,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T00:00:00Z","timestamp":1206403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1038\/ncprheum0770","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T16:57:50Z","timestamp":1206464270000},"page":"250-257","source":"Crossref","is-referenced-by-count":54,"title":["Therapy Insight: preserving fertility in cyclophosphamide-treated patients with rheumatic disease"],"prefix":"10.1038","volume":"4","author":[{"given":"Mary Anne","family":"Dooley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,25]]},"reference":[{"key":"BFncprheum0770_CR1","volume-title":"Kelley's Textbook of Rheumatology","author":"ED Harris Jr","year":"2005","unstructured":"Harris ED Jr and Ruddy S (2005) Kelley's Textbook of Rheumatology. Philadelphia: Elsevier\/Saunders"},{"key":"BFncprheum0770_CR2","unstructured":"Appel GB et al. (2007) Mycophenolate mofetil compared with intravenous cyclophosphamide as induction therapy for lupus nephritis. Presented at Renal Week 2007, the American Society of Nephrology Annual Meeting: 2007 October 31\u2013November 5, San Francisco, CA"},{"key":"BFncprheum0770_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/art.10534","volume":"47","author":"L Fraenkel","year":"2002","unstructured":"Fraenkel L et al. (2002) Patient preferences for treatment of lupus nephritis. Arthritis Rheum 47: 421\u2013428","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0770_CR4","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.2006.10.2020","volume":"25","author":"MA van der Kaaij","year":"2007","unstructured":"van der Kaaij MA et al. (2007) Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 25: 2825\u20132832","journal-title":"J Clin Oncol"},{"key":"BFncprheum0770_CR5","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1001\/jama.1979.03300170023020","volume":"242","author":"RM Chapman","year":"1979","unstructured":"Chapman RM et al. (1979) Cytotoxic-induced ovarian failure in women with Hodgkin's disease. JAMA 242: 1877\u20131881","journal-title":"JAMA"},{"key":"BFncprheum0770_CR6","first-page":"23","volume":"32","author":"Z Blumenfeld","year":"2007","unstructured":"Blumenfeld Z (2007) Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy. Minerva Endocrinol 32: 23\u201334","journal-title":"Minerva Endocrinol"},{"key":"BFncprheum0770_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/art.1780160204","volume":"16","author":"JF Fries","year":"1973","unstructured":"Fries JF et al. (1973) Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis. Arthritis Rheum 16: 154\u2013162","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0770_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1056\/NEJM197311292892202","volume":"289","author":"GL Warne","year":"1973","unstructured":"Warne GL et al. (1973) Cyclophosphamide-induced ovarian failure. N Engl J Med 289: 1159\u20131162","journal-title":"N Engl J Med"},{"key":"BFncprheum0770_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0140-6736(72)90502-8","volume":"2","author":"PR Uldall","year":"1972","unstructured":"Uldall PR et al. (1972) Sterility and cyclophosphamide. Lancet 2: 693\u2013694","journal-title":"Lancet"},{"key":"BFncprheum0770_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/1529-0131(199806)41:6<1090::AID-ART16>3.0.CO;2-6","volume":"41","author":"CC Mok","year":"1998","unstructured":"Mok CC et al. (1998) Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 41: 831\u2013837","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0770_CR11","doi-asserted-by":"publisher","first-page":"366","DOI":"10.7326\/0003-4819-119-5-199309010-00003","volume":"119","author":"DT Boumpas","year":"1993","unstructured":"Boumpas DT et al. (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119: 366\u2013369","journal-title":"Ann Intern Med"},{"key":"BFncprheum0770_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/ard.55.4.224","volume":"55","author":"EM McDermott","year":"1996","unstructured":"McDermott EM and Powell RJ (1996) Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide. Ann Rheum Dis 55: 224\u2013229","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0770_CR13","first-page":"2129","volume":"29","author":"JP Ioannidis","year":"2002","unstructured":"Ioannidis JP et al. (2002) Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol 29: 2129\u20132135","journal-title":"J Rheumatol"},{"key":"BFncprheum0770_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-0897.1992.tb00780.x","volume":"28","author":"P Langevitz","year":"1992","unstructured":"Langevitz P et al. (1992) The effect of cyclophosphamide pulses on fertility in patients with lupus nephritis. Am J Reprod Immunol 28: 157\u2013158","journal-title":"Am J Reprod Immunol"},{"key":"BFncprheum0770_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00254570","volume":"19","author":"JH Waxman","year":"1987","unstructured":"Waxman JH et al. (1987) Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol 19: 159\u2013162","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFncprheum0770_CR16","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1002\/1097-0142(19850515)55:10<2364::AID-CNCR2820551011>3.0.CO;2-E","volume":"55","author":"SV Nicosia","year":"1985","unstructured":"Nicosia SV et al. (1985) Gonadal effects of cancer therapy in girls. Cancer 55: 2364\u20132372","journal-title":"Cancer"},{"key":"BFncprheum0770_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0002-9343(82)90541-1","volume":"72","author":"FP Kuhajda","year":"1982","unstructured":"Kuhajda FP et al. (1982) Gonadal morphology in patients receiving chemotherapy for leukemia: evidence for reproductive potential and against testicular tumor sanctuary. Am J Med 72: 759\u2013767","journal-title":"Am J Med"},{"key":"BFncprheum0770_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0022-3476(78)80092-4","volume":"92","author":"A Parra","year":"1978","unstructured":"Parra A et al. (1978) Plasma gonadotropins and gonadal steroids in children treated with cyclophosphamide. J Pediatr 92: 117\u2013124","journal-title":"J Pediatr"},{"key":"BFncprheum0770_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/BF00869818","volume":"4","author":"R Bogdanovic","year":"1990","unstructured":"Bogdanovic R et al. (1990) Testicular function following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study. Pediatr Nephrol 4: 451\u2013454","journal-title":"Pediatr Nephrol"},{"key":"BFncprheum0770_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0022-3476(77)81305-X","volume":"91","author":"RD Lentz","year":"1977","unstructured":"Lentz RD et al. (1977) Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty. J Pediatr 91: 385\u2013394","journal-title":"J Pediatr"},{"key":"BFncprheum0770_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/sct.1990.6.83","volume":"6","author":"K Ataya","year":"1990","unstructured":"Ataya K et al. (1990) The uptake and metabolism of cyclophosphamide by the ovary. Sel Cancer Ther 6: 83\u201392","journal-title":"Sel Cancer Ther"},{"key":"BFncprheum0770_CR22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood.V58.4.849.849","volume":"58","author":"RM Chapman","year":"1981","unstructured":"Chapman RM and Sutcliffe SB (1981) Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood 58: 849\u2013851","journal-title":"Blood"},{"key":"BFncprheum0770_CR23","first-page":"151","volume":"10","author":"A Longhi","year":"2003","unstructured":"Longhi A et al. (2003) Effect of oral contraceptive on ovarian function in young females undergoing neoadjuvant chemotherapy treatment for osteosarcoma. Oncol Rep 10: 151\u2013155","journal-title":"Oncol Rep"},{"key":"BFncprheum0770_CR24","first-page":"273","volume-title":"Dubois' Lupus Erythematosus","author":"SE Walker","year":"2007","unstructured":"Walker SE (2007) The importance of sex hormones in systemic lupus erythematosus. In Dubois' Lupus Erythematosus, edn 7, 273\u2013285 (Eds Wallace DJ and Hahn BH) Baltimore: Williams & Wilkins"},{"key":"BFncprheum0770_CR25","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa051135","volume":"353","author":"M Petri","year":"2005","unstructured":"Petri M et al. (2005) Combined oral contraceptives in women with systemic lupus erythematosus: the OC-SELENA Trial. N Engl J Med 353: 2550\u20132558","journal-title":"N Engl J Med"},{"key":"BFncprheum0770_CR26","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1056\/NEJMoa050817","volume":"353","author":"J Sanchez-Guerrero","year":"2005","unstructured":"Sanchez-Guerrero J et al. (2005) A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 353: 2539\u20132549","journal-title":"N Engl J Med"},{"key":"BFncprheum0770_CR27","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1002\/art.22855","volume":"56","author":"J Sanchez-Guerrero","year":"2007","unstructured":"Sanchez-Guerrero J et al. (2007) Menopause hormonal therapy in women with systemic lupus erythematosus. Arthritis Rheum 56: 3070\u20133079","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0770_CR28","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","volume":"142","author":"JP Buyon","year":"2005","unstructured":"Buyon JP et al. (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142: 953\u2013962","journal-title":"Ann Intern Med"},{"key":"BFncprheum0770_CR29","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/art.21263","volume":"52","author":"EC Somers","year":"2005","unstructured":"Somers EC et al. (2005) Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum 52: 2761\u20132767","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0770_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0015-0282(16)60486-7","volume":"51","author":"AJ Friedman","year":"1989","unstructured":"Friedman AJ et al. (1989) A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata. Fertil Steril 51: 251\u2013256","journal-title":"Fertil Steril"},{"key":"BFncprheum0770_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00001703-200310000-00003","volume":"15","author":"Z Blumenfeld","year":"2003","unstructured":"Blumenfeld Z (2003) Gynaecologic concerns for young women exposed to gonadotoxic chemotherapy. Curr Opin Obstet Gynecol 15: 359\u2013370","journal-title":"Curr Opin Obstet Gynecol"},{"key":"BFncprheum0770_CR32","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/oxfordjournals.humrep.a019457","volume":"11","author":"Z Blumenfeld","year":"1996","unstructured":"Blumenfeld Z et al. (1996) Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 11: 1620\u20131626","journal-title":"Hum Reprod"},{"key":"BFncprheum0770_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1191\/096120300678828596","volume":"9","author":"Z Blumenfeld","year":"2000","unstructured":"Blumenfeld Z et al. (2000) Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus 9: 401\u2013405","journal-title":"Lupus"},{"key":"BFncprheum0770_CR34","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.fertnstert.2006.10.004","volume":"87","author":"C Castelo-Branco","year":"2007","unstructured":"Castelo-Branco C et al. (2007) Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy. Fertil Steril 87: 702\u2013705","journal-title":"Fertil Steril"},{"key":"BFncprheum0770_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00254570","volume":"19","author":"JH Waxman","year":"1987","unstructured":"Waxman JH et al. (1987) Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol 19: 159\u2013162","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFncprheum0770_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/jncimonographs\/lgi015","volume":"34","author":"Z Blumenfeld","year":"2005","unstructured":"Blumenfeld Z and Eckman A (2005) Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J Natl Cancer Inst Monogr 34: 40\u201343","journal-title":"J Natl Cancer Inst Monogr"},{"key":"BFncprheum0770_CR37","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1210\/endo.135.5.7956897","volume":"135","author":"C Peng","year":"1994","unstructured":"Peng C et al. (1994) Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology 135: 1740\u20131746","journal-title":"Endocrinology"},{"key":"BFncprheum0770_CR38","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1634\/theoncologist.12-9-1044","volume":"12","author":"Z Blumenfeld","year":"2007","unstructured":"Blumenfeld Z (2007) How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist 12: 1044\u20131054","journal-title":"Oncologist"},{"key":"BFncprheum0770_CR39","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0015-0282(16)54648-2","volume":"56","author":"R Barbieri","year":"1991","unstructured":"Barbieri R et al. (1991) GnRH agonists and ovarian hyperstimulation. Fertil Steril 56: 376\u2013377","journal-title":"Fertil Steril"},{"key":"BFncprheum0770_CR40","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1210\/jcem-67-4-701","volume":"67","author":"JS Johansen","year":"1988","unstructured":"Johansen JS et al. (1988) The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism. J Clin Endocrinol Metab 67: 701\u2013706","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncprheum0770_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2265.1988.tb00248.x","volume":"29","author":"WH Matta","year":"1988","unstructured":"Matta WH et al. (1988) Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women. Clin Endocrinol 29: 45\u201351","journal-title":"Clin Endocrinol"},{"issue":"Suppl","key":"BFncprheum0770_CR42","first-page":"4329","volume":"40","author":"MA Dooley","year":"1998","unstructured":"Dooley MA et al. (1998) Variable bone mineral density changes in women receiving depot leuprolide acetate during cyclophosphamide therapy for severe lupus nephritis [abstract]. Arthritis Rheum 40 (Suppl): 4329","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0770_CR43","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.fertnstert.2004.12.030","volume":"83","author":"DR Danforth","year":"2005","unstructured":"Danforth DR et al. (2005) Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil Steril 83: 1333\u20131338","journal-title":"Fertil Steril"},{"key":"BFncprheum0770_CR44","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/humrep\/deh257","volume":"19","author":"D Meirow","year":"2004","unstructured":"Meirow D et al. (2004) The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum Reprod 19: 1294\u20131299","journal-title":"Hum Reprod"},{"key":"BFncprheum0770_CR45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1745-7262.2006.00206.x","volume":"8","author":"T Maltaris","year":"2006","unstructured":"Maltaris T et al. (2006) Gonadal damage and options for fertility preservation in female and male cancer survivors. Asian J Androl 8: 515\u2013533","journal-title":"Asian J Androl"},{"key":"BFncprheum0770_CR46","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2004) Ovarian tissue and oocyte cryopreservation. Fertil Steril 82: 993\u2013998","DOI":"10.1016\/S0015-0282(04)02260-5"},{"key":"BFncprheum0770_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0093-691X(99)00240-X","volume":"53","author":"JM Shaw","year":"2000","unstructured":"Shaw JM et al. (2000) Fundamental cryobiology of mammalian oocytes and ovarian tissue. Theriogenology 53: 59\u201372","journal-title":"Theriogenology"},{"key":"BFncprheum0770_CR48","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1093\/oxfordjournals.humrep.a136182","volume":"10","author":"SG Baka","year":"1995","unstructured":"Baka SG et al. (1995) Evaluation of the spindle apparatus of in vitro matured human oocytes following cryopreservation. Hum Reprod 10: 1816\u20131820","journal-title":"Hum Reprod"},{"key":"BFncprheum0770_CR49","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/humrep\/12.7.1550","volume":"12","author":"PL Matson","year":"1997","unstructured":"Matson PL et al. (1997) Cryopreservation of oocytes and embryos: use of a mouse model to investigate effects upon zona hardness and formulate treatment strategies in an in-vitro fertilization programme. Hum Reprod 12: 1550\u20131553","journal-title":"Hum Reprod"},{"key":"BFncprheum0770_CR50","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine; Practice Committee of the Society for Assisted Reproductive Technology (2006) Ovarian tissue and oocyte cryopreservation. Fertil Steril 86 (Suppl): S142\u2013S147","DOI":"10.1016\/j.fertnstert.2006.08.083"},{"key":"BFncprheum0770_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S1472-6483(10)60766-3","volume":"14","author":"M Antinori","year":"2007","unstructured":"Antinori M et al. (2007) Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod Biomed Online 14: 72\u201379","journal-title":"Reprod Biomed Online"},{"key":"BFncprheum0770_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.theriogenology.2006.09.014","volume":"67","author":"M Kuwayama","year":"2007","unstructured":"Kuwayama M (2007) Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology 67: 72\u201379","journal-title":"Theriogenology"},{"key":"BFncprheum0770_CR53","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/oxfordjournals.humrep.a138572","volume":"9","author":"DA Gook","year":"1994","unstructured":"Gook DA et al. (1994) Fertilization of human oocytes following cryopreservation; normal karyotypes and absence of stray chromosomes. Hum Reprod 9: 684\u2013691","journal-title":"Hum Reprod"},{"key":"BFncprheum0770_CR54","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0015-0282(00)01725-8","volume":"75","author":"A Cobo","year":"2001","unstructured":"Cobo A et al. (2001) Use of fluorescence in situ hybridization to assess the chromosomal status of embryos obtained from cryopreserved oocytes. Fertil Steril 75: 354\u2013360","journal-title":"Fertil Steril"},{"key":"BFncprheum0770_CR55","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1210\/endo.140.1.6453","volume":"1401","author":"DT Baird","year":"1999","unstructured":"Baird DT et al. (1999) Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at \u2212196 \u00b0C. Endocrinology 1401: 462\u2013471","journal-title":"Endocrinology"},{"key":"BFncprheum0770_CR56","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/humrep\/15.6.1300","volume":"15","author":"CJ Candy","year":"2000","unstructured":"Candy CJ et al. (2000) Restoration of a normal reproductive lifespan after grafting of cryopreserved mouse ovaries. Hum Reprod 15: 1300\u20131304","journal-title":"Hum Reprod"},{"key":"BFncprheum0770_CR57","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/humrep\/17.3.612","volume":"17","author":"J Schnorr","year":"2002","unstructured":"Schnorr J et al. (2002) Functional studies of subcutaneous ovarian transplants in non-human primates: steroidogenesis, endometrial development, ovulation, menstrual patterns and gamete morphology. Hum Reprod 17: 612\u2013619","journal-title":"Hum Reprod"},{"key":"BFncprheum0770_CR58","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/428137a","volume":"428","author":"DM Lee","year":"2004","unstructured":"Lee DM et al. (2004) Live birth after ovarian tissue transplant. Nature 428: 137\u2013138","journal-title":"Nature"},{"key":"BFncprheum0770_CR59","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1095\/biolreprod.106.054833","volume":"75","author":"M Xu","year":"2006","unstructured":"Xu M et al. (2006) Identification of a stage-specific in vitro culture environment for follicle growth and oocyte development. Biol Reprod 75: 916\u2013923","journal-title":"Biol Reprod"},{"key":"BFncprheum0770_CR60","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.biomaterials.2005.06.016","volume":"27","author":"PK Kreeger","year":"2006","unstructured":"Kreeger PK et al. (2006) The in vitro regulation of ovarian follicle development using alginate\u2013extracellular matrix gels. Biomaterials 27: 714\u2013723","journal-title":"Biomaterials"},{"key":"BFncprheum0770_CR61","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1002\/1097-0142(19921201)70:11<2703::AID-CNCR2820701123>3.0.CO;2-X","volume":"70","author":"ML Meistrich","year":"1992","unstructured":"Meistrich ML et al. (1992) Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewings and soft tissue sarcomas. Cancer 70: 2703\u20132712","journal-title":"Cancer"},{"key":"BFncprheum0770_CR62","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.reprotox.2006.04.020","volume":"22","author":"A Garolla","year":"2006","unstructured":"Garolla A et al. (2006) Progress in the development of childhood cancer therapy. Reprod Toxicol 22: 126\u2013132","journal-title":"Reprod Toxicol"},{"key":"BFncprheum0770_CR63","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1093\/humrep\/deh518","volume":"19","author":"KL Schmidt","year":"2004","unstructured":"Schmidt KL et al. (2004) Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples. Hum Reprod 19: 2806\u20132810","journal-title":"Hum Reprod"},{"key":"BFncprheum0770_CR64","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7326\/0003-4819-126-4-199702150-00005","volume":"15","author":"A Masala","year":"1997","unstructured":"Masala A et al. (1997) Use of testosterone to prevent cyclophosphamide-induced azoospermia. Ann Intern Med 15: 292\u2013295","journal-title":"Ann Intern Med"},{"key":"BFncprheum0770_CR65","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1093\/humrep\/dem066","volume":"22","author":"Z Blumenfeld","year":"2007","unstructured":"Blumenfeld Z et al. (2007) Spontaneous pregnancy and normal delivery after repeated autologous bone marrow transplantation and GnRH agonist treatment. Hum Reprod 22: 2346","journal-title":"Hum Reprod"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0770.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0770","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0770.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:11:17Z","timestamp":1684444277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,25]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["BFncprheum0770"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0770","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,25]]}}}